Petition for Inter Partes Review by Bio-Techne Corporation

On November 3, 2015, Bio-Techne Corporation and ProteinSimple (“Petitioners”) filed a Petition to the USPTO’s Patent Trial and Appeal Board (“Board”) for inter partes review of  claims 1, 3, 5-7, 14, 15, and 17-20 of U.S. Patent No. 6,834,240 (“the ‘240 Patent”). The ‘240 Patent is owned by Caliper Life Sciences, Inc. and/or PerkinElmer, Inc.  The ‘240 Patent, which issued on December 21, 2004, is drawn to a system for displaying data associated with the analysis of macromolecular structures.  In the Petition, Petitioners assert that claims 1, 3, 5-7, 14, 15, and 17-20 of the ‘240 Patent are anticipated under 35 U.S.C. § 102(e) over U.S. Patent No. 5,963,456 (“Klein”) and/or obvious under 35 U.S.C. § 103(a) over Klein in view of other patent documents.  The inter partes review remains pending at the Board and is captioned IPR2016-00139.

By:  Jacqueline A. DiRamio

View Attachment (PDF)